bromopyruvic acid glutathione 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis Glutathione-Mediated Conjugation of Anticancer Drugs:
Glutathione Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation PMC 3 Bromopyruvic Acid (3 BP, Bromopyruvic acid, NSC 11731, NSC 62343, CAS Number: 1113 59 3) Cayman Chemical Anticancer agent 3 bromopyruvic acid forms a conjugate with glutathione Pharmacological Reports Springer Nature Link Glutathione: Lights and Shadows in Cancer Patients PMC Experimental and Therapeutic Medicine
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14




